Article

Stathmin 1 Expression in Neuroendocrine and Proliferating Prostate Cancer

2024-12-09

Abstract excerpt

<title>Abstract</title> <p>Prostate cancer (PCa) is the second leading cause of cancer-related mortality among men in the United States. While PCa initially responds to androgen deprivation therapy, a significant portion progresses to castration-resistant PCa. Approximately 20–25% of these cases acquire aggressive neuroendocrine (NE) features, ultimately leading to neuroendocrine prostate cancer (NEPC). In this s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bd9921fc-3bad-5ea8-ad02-772a77e0aa2c
DOI: 10.21203/rs.3.rs-5279702/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Stathmin 1 Expression in Neuroendocrine and Proliferating Prostate CancerDOI 10.21203/rs.3.rs-5279702/v1Read

Unmasking Neuroendocrine Prostate Cancer with a Machine Learning-Driven 7-Gene Stemness Signature that Predicts ProgressionSemantic proximity Read

Distinct prostate cancer neuroendocrine subtypes predict prognosis and guide personalized prostate-specific membrane antigen-targeted therapySemantic proximity Read

Single-cell sequencing analysis revealed that NEAT1 was a potential biomarker and therapeutic target of prostate cancerSemantic proximity Read

PAX6 promotes neuroendocrine phenotypes of prostate cancer via enhancing MET/STAT5A-mediated chromatin accessibility.Semantic proximity Read

Role of MicroRNAs in Neuroendocrine Prostate CancerSemantic proximity Read

INSM1 Regulates Neuroendocrine Plasticity and Tumor Progression in Prostate CancerSemantic proximity Read

Defining focal neuroendocrine differentiation as a transcriptionally distinct form of prostate cancer pathology characterized by the expression of androgen receptorsSemantic proximity Read

ONECUT2 is a driver of neuroendocrine prostate cancerSemantic proximity Read

Neuroendocrine transdifferentiation in human cancer: molecular mechanisms and therapeutic targetsSemantic proximity Read

Establishment of a neuroendocrine prostate cancer model driven by the RNA splicing factor SRRM4Semantic proximity Read

L1CAM mediates neuroendocrine phenotype acquisition in prostate cancer cells.Semantic proximity Read

Molecular model for neuroendocrine prostate cancer progressionSemantic proximity Read